Prescribing Dementia Drugs

AARP Puts the Spotlight on Prescribing of Dementia Drugs

  Seventy percent of elderly dementia patients prescribed dementia drugs are on them long-term despite the lack of evidence that they provide any benefit beyond one year, says a new report released by the AARP Public Policy Institute.  Reducing overuse of dementia drugs could result in substantial savings, estimating $20,000 per patient, for patients insurers.…

Read More